The Enterprise Value as of December 2025 (TTM) for RepliCel Life Sciences Inc. (REPCF) is 2.20M

According to RepliCel Life Sciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.20M. This represents a change of -0.51% compared to the average of 2.21M of the last 4 quarters.

RepliCel Life Sciences Inc. (REPCF) Historical Enterprise Value (quarterly & annually)

How has REPCF Enterprise Value performed in the past?

The mean historical Enterprise Value of RepliCel Life Sciences Inc. over the last ten years is 6.24M. The current 2.20M Enterprise Value has changed 3.42% with respect to the historical average. Over the past ten years (40 quarters), REPCF's Enterprise Value was at its highest in in the March 2015 quarter at 29.32M. The Enterprise Value was at its lowest in in the September 2024 quarter at 0.

RepliCel Life Sciences Inc. (REPCF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of RepliCel Life Sciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

RepliCel Life Sciences Inc. (REPCF) Average Enterprise Value

How has REPCF Enterprise Value performed in the past?

The current Enterprise Value of RepliCel Life Sciences Inc. (REPCF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

RepliCel Life Sciences Inc. (REPCF) Enterprise Value vs. Peers

How is REPCF’s Enterprise Value compared to its peers?

RepliCel Life Sciences Inc.’s Enterprise Value is greater than ProtoKinetix, Incorporated (1.76M), less than Acrux Limited (9.34M), less than Sigyn Therapeutics, Inc. (5.94M), greater than HAVN Life Sciences Inc. (487.77K), less than Zelira Therapeutics Limited (6.18M), greater than Regen BioPharma, Inc. (1.32M), less than AXIM Biotechnologies, Inc. (14.70M), less than Mosaic ImmunoEngineering Inc. (5.39M), less than Therma Bright Inc. (2.90M), less than Restart Life Sciences Corp. (3.44M),

Build a custom stock screener for RepliCel Life Sciences Inc. (REPCF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RepliCel Life Sciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RepliCel Life Sciences Inc. (REPCF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RepliCel Life Sciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.